Sunshine Guojian Pharmaceutical Shanghai's (SHA:688336) net profit attributable to shareholders in the first half jumped 95% to 371.3 million yuan from 190.3 million yuan a year earlier, according to a Shanghai bourse filing on Friday.
Earnings per share increased year on year to 0.41 yuan from 0.21 yuan.
Operating revenue climbed 35% to 865.7 million yuan from 642 million yuan in the prior year.
The Chinese drugmaker also proposed a cash dividend payout of 0.42 yuan for every 10 shares to all shareholders.
The company's shares fell 2% during the afternoon trade.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments